RETRACTED ARTICLE:SUMO-specific protease 6 promotes gastric cancer cell growth via deSUMOylation of FoxM1

Tumor Biology

Volumn 36, Issue 12, 2015, Pages 9865-9871

  Song, Jiu Gang ^a   Xie, Hua Hong ^b   Li, Nan ^a   Wu, Kai ^a   Qiu, Ji gang ^c   Shen, Da Ming ^c   Huang, Chun Jin ^c  

^a 309TH HOSPITAL OF PLA   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Cell growth; FoxM1; Gastric cancer; SENP6; SUMOylation

Indexed keywords

FORKHEAD BOX PROTEIN M1; FORKHEAD TRANSCRIPTION FACTOR; MESSENGER RNA; SUMO PROTEIN; SUMO SPECIFIC PROTEASE 6; UNCLASSIFIED DRUG; CYSTEINE PROTEINASE; FOXM1 PROTEIN, HUMAN; SENP6 PROTEIN, HUMAN;

ARTICLE; CANCER GROWTH; CONTROLLED STUDY; DESUMOYLATION; GASTRIC CANCER CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; STOMACH CANCER; STOMACH CARCINOGENESIS; TRANSACTIVATION; TRANSCRIPTION REGULATION; BIOSYNTHESIS; CARCINOGENESIS; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; STOMACH TUMOR; SUMOYLATION; TUMOR CELL LINE;

CARCINOGENESIS; CELL LINE, TUMOR; CELL PROLIFERATION; CYSTEINE ENDOPEPTIDASES; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, MESSENGER; STOMACH NEOPLASMS; SUMOYLATION;

EID: 84946814718     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-3737-z     Document Type: TB

References (29)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.
2. Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374:477–90.
3. Muller S, Ledl A, Schmidt D. Sumo: a regulator of gene expression and genome integrity. Oncogene. 2004;23:1998–2008.
4. Bossis G, Melchior F. Sumo: regulating the regulator. Cell Div. 2006;1:13.
5. Geiss-Friedlander R, Melchior F. Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol. 2007;8:947–56.
6. Nacerddine K, Lehembre F, Bhaumik M, Artus J, Cohen-Tannoudji M, Babinet C, et al. The sumo pathway is essential for nuclear integrity and chromosome segregation in mice. Dev Cell. 2005;9:769–79.
7. Baek SH. A novel link between sumo modification and cancer metastasis. Cell Cycle. 2006;5:1492–5. Georgetown, Tex.
8. Mukhopadhyay D, Dasso M. Modification in reverse: the sumo proteases. Trends Biochem Sci. 2007;32:286–95.
9. Guo C, Henley JM. Wrestling with stress: roles of protein sumoylation and desumoylation in cell stress response. IUBMB Life. 2014;66:71–7.
10. Shen HJ, Zhu HY, Yang C, Ji F. Senp2 regulates hepatocellular carcinoma cell growth by modulating the stability of beta-catenin. Asian Pac J Cancer Prev. 2012;13:3583–7.
11. Qian J, Luo Y, Gu X, Wang X. Inhibition of senp6-induced radiosensitization of human hepatocellular carcinoma cells by blocking radiation-induced nf-kappab activation. Cancer Biother Radiopharm. 2013;28:196–200.
12. Mukhopadhyay D, Ayaydin F, Kolli N, Tan SH, Anan T, Kametaka A, et al. Susp1 antagonizes formation of highly sumo2/3-conjugated species. J Cell Biol. 2006;174:939–49.
13. Mukhopadhyay D, Arnaoutov A, Dasso M. The sumo protease senp6 is essential for inner kinetochore assembly. J Cell Biol. 2010;188:681–92.
14. Dou H, Huang C, Singh M, Carpenter PB, Yeh ET. Regulation of DNA repair through desumoylation and sumoylation of replication protein a complex. Mol Cell. 2010;39:333–45.
15. Hattersley N, Shen L, Jaffray EG, Hay RT. The sumo protease senp6 is a direct regulator of pml nuclear bodies. Mol Biol Cell. 2011;22:78–90.
16. Rojas-Fernandez A, Plechanovova A, Hattersley N, Jaffray E, Tatham MH, Hay RT. Sumo chain-induced dimerization activates rnf4. Mol Cell. 2014;53:880–92.
17. Wierstra I. The transcription factor foxm1 (forkhead box m1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles. Adv Cancer Res. 2013;118:97–398.
18. Halasi M, Gartel AL. Fox (m1) news—it is cancer. Mol Cancer Ther. 2013;12:245–54.
19. Xu XS, Miao RC, Wan Y, Zhang LQ, Qu K, Liu C. Foxm1 as a novel therapeutic target for cancer drug therapy. Asian Pac J Cancer Prev. 2015;16:23–9.
20. Xu N, Wu SD, Wang H, Wang Q, Bai CX. Involvement of foxm1 in non-small cell lung cancer recurrence. Asian Pac J Cancer Prev. 2012;13:4739–43.
21. Wang Z, Banerjee S, Kong D, Li Y, Sarkar FH. Down-regulation of forkhead box m1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res. 2007;67:8293–300.
22. Schimmel J, Eifler K, Sigurethsson JO, Cuijpers SA, Hendriks IA, Verlaan-de Vries M, et al. Uncovering sumoylation dynamics during cell-cycle progression reveals foxm1 as a key mitotic sumo target protein. Mol Cell. 2014;53:1053–66.
23. Zhang J, Yuan C, Wu J, Elsayed Z, Fu Z. Polo-like kinase 1-mediated phosphorylation of forkhead box protein m1b antagonizes its sumoylation and facilitates its mitotic function. J Biol Chem. 2015;290:3708–19.
24. McDowall MD, Scott MS, Barton GJ. Pips: human protein-protein interaction prediction database. Nucleic Acids Res. 2009;37:D651–6.
25. Wierstra I, Alves J. Foxm1, a typical proliferation-associated transcription factor. Biol Chem. 2007;388:1257–74.
26. Kalin TV, Ustiyan V, Kalinichenko VV. Multiple faces of foxm1 transcription factor: lessons from transgenic mouse models. Cell cycle. 2011;10:396–405. Georgetown, Tex.
27. Le Lay J, Kaestner KH. The fox genes in the liver: from organogenesis to functional integration. Physiol Rev. 2010;90:1–22.
28. Chen W, Yuan K, Tao ZZ, Xiao BK. Deletion of forkhead box m1 transcription factor reduces malignancy in laryngeal squamous carcinoma cells. Asian Pac J Cancer Prev. 2011;12:1785–8.
29. Raychaudhuri P, Park HJ. Foxm1: a master regulator of tumor metastasis. Cancer Res. 2011;71:4329–33.